Skip to main content
Journal cover image

Positron emission tomography for the evaluation of pancreatic disease.

Publication ,  Journal Article
Kirchner, PT; Ryan, J; Zalutsky, M; Harper, PV
Published in: Semin Nucl Med
October 1980

Efficient techniques for native-labeling of amino acids have been combined successfully with emission tomography to yield significant improvements in pancreatic imaging. Carbon-11-labeled tryptophan appears to be the best agent available currently for imaging the pancreas. Optimum scanning times begin 30 min after tracer administration. Positron emission tomography with 11C-tryptophan is capable of defining both morphological and functional alterations in the pancreas. Tumors as small as 2 cm in diameter can be detected, but reliable differentiation of pancreatic cancer from pancreatis may not be possible even with this improved imaging technique. Longitudinal multiplane emission tomography in single-photon mode with the Pho/Con provides an efficient and satisfactory approach to pancreatic imaging with the positron-emitting radiopharmaceuticals.

Duke Scholars

Published In

Semin Nucl Med

DOI

ISSN

0001-2998

Publication Date

October 1980

Volume

10

Issue

4

Start / End Page

374 / 391

Location

United States

Related Subject Headings

  • Tryptophan
  • Tomography, Emission-Computed
  • Radiation Dosage
  • Pancreatitis
  • Pancreatic Neoplasms
  • Pancreatic Diseases
  • Pancreas
  • Nuclear Medicine & Medical Imaging
  • Isotope Labeling
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kirchner, P. T., Ryan, J., Zalutsky, M., & Harper, P. V. (1980). Positron emission tomography for the evaluation of pancreatic disease. Semin Nucl Med, 10(4), 374–391. https://doi.org/10.1016/s0001-2998(80)80039-0
Kirchner, P. T., J. Ryan, M. Zalutsky, and P. V. Harper. “Positron emission tomography for the evaluation of pancreatic disease.Semin Nucl Med 10, no. 4 (October 1980): 374–91. https://doi.org/10.1016/s0001-2998(80)80039-0.
Kirchner PT, Ryan J, Zalutsky M, Harper PV. Positron emission tomography for the evaluation of pancreatic disease. Semin Nucl Med. 1980 Oct;10(4):374–91.
Kirchner, P. T., et al. “Positron emission tomography for the evaluation of pancreatic disease.Semin Nucl Med, vol. 10, no. 4, Oct. 1980, pp. 374–91. Pubmed, doi:10.1016/s0001-2998(80)80039-0.
Kirchner PT, Ryan J, Zalutsky M, Harper PV. Positron emission tomography for the evaluation of pancreatic disease. Semin Nucl Med. 1980 Oct;10(4):374–391.
Journal cover image

Published In

Semin Nucl Med

DOI

ISSN

0001-2998

Publication Date

October 1980

Volume

10

Issue

4

Start / End Page

374 / 391

Location

United States

Related Subject Headings

  • Tryptophan
  • Tomography, Emission-Computed
  • Radiation Dosage
  • Pancreatitis
  • Pancreatic Neoplasms
  • Pancreatic Diseases
  • Pancreas
  • Nuclear Medicine & Medical Imaging
  • Isotope Labeling
  • Humans